Sign up Australia
Proactive Investors - Run By Investors For Investors

FYI Resources confirms kaolin resource suitable for high-purity alumina feedstock

The company aims to mine and process its kaolin into high-purity alumina (HPA).
rc drill rig in paddock
Kaolin is a superior quality aluminous clay with industrial value

FYI Resources Ltd (ASX:FYI) has received results from a reverse circulation (RC) drilling program at its 100% owned Cadoux kaolin project in Western Australia.

Importantly, analysis of the results has confirmed that the kaolin is an ideal feedstock for refining into high-purity alumina (HPA), a valuable new-age material.

The resource’s high-grade nature and it being low in deleterious minerals highlight its potential value.

75 drill holes averaging 21.5 metres depth

The RC drill program comprised of 75 holes totalling 1,613 metres for an average hole depth of 21.5 metres.

Drilling was designed to collect data for metallurgical studies and to better understand and interpret the geological model.

FYI’s managing director Roland Hill said: “Having attended the drilling program at site and seeing first hand the visual indications, the results of the second phase RC drilling are very pleasing.

“The drilling program demonstrates FYI is progressing with a very robust development strategy and we will continue to deliver the best possible project outcome.”

Updating the resource model

Data from this drilling will also be incorporated into a revised resource model which is underway.

The current JORC resource totals 16.1 million tonnes grading 11.76% aluminium.

View full FYI profile View Profile

FYI Resources Ltd Timeline

Related Articles

bacteria
Thu
Following the disappointment of its DMD treatment over summer, Summit is leveraging its Discuva platform to develop new antibiotics, which doctors are in desperate need of
scientist with vial
August 09 2018
The AIM-listed drug developer is at the vanguard of advances in the emerging field of immuno-oncology
mri scanner
September 12 2018
IXICO is actively supporting the hunt for breakthrough treatments for Alzheimer’s, Parkinson’s, Huntington’s and multiple sclerosis

No investment advice

The information on this Site is of a general nature only. It does not take your specific needs or circumstances into consideration, so you should look at your own financial position, objectives and requirements and seek financial advice before making any financial decisions. You acknowledge and understand that neither the Company, its related bodies corporate, the information providers or their affiliates will advise you personally about the nature, potential value or suitability of any particular security, portfolio of securities, transaction, investment strategy, or other matter. You should read our FSG and any other relevant disclosure documents and if necessary seek persona advice prior to making any investment decision.

You understand and agree that no Content (as defined below) published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is suitable or advisable for any specific person.

You understand that in certain circumstances the Company, its related bodies corporate, the information providers or their affiliates may have received, or be entitled to receive, financial or other consideration in connection with promoting, and providing information about, certain entities on the Site and in communications otherwise provided to you.

You understand that price and other data is supplied by sources believed to be reliable, that the calculations herein are made using such data, and that neither such data nor such calculations are guaranteed by these sources, the Company, the information providers or any other person or entity, and may not be complete or accurate. From time to time, reference may be made in our marketing materials to prior articles and opinions we have published. These references may be selective, may reference only a portion of an article or recommendation, and are likely not to be current. As markets change continuously, previously published information and data may not be current and should not be relied upon.

Before you act on any general advice we provide, please consider whether it is appropriate for your personal circumstances.

© Proactive Investors 2018

Proactive Investors Australia PTY LTD ACN:132787654 ABN:19132787654.

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use